Allgood, VE et al. "Analysis of chicken progesterone receptor function and phosphorylation using an adenovirus-mediated procedure for high-efficiency DNA transfer," Biochemistry, 36(l):224-232 (1997). |
Arends, MJ et al. "Apoptosis: Mechanisms and roles in pathology," Int Rev Exp Pathol, 32:223-254 (1991). |
Arrick, BA et al. "Differential regulation of three transforming growth factor b species in human breast cancer cell lines by estradiol," Cancer Res., 50:299-303 (1990). |
Bai, W et al. " Differential phosphorylation of chicken progesterone receptor in hormone-dependent and Ligand-independent activation," J Biol Chem, 272(16):10457-10463 (1997). |
Bates, R.C. et al. "Involvement of integrins in cell survival," Cancer Metastasis Rev, 14(3):191-203 (1995). |
Berchuck, A. et al., "Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth, factor-.beta.," Am J Obstet Gynecol, 166: 676-84 (1992). |
Berchuck, A. et al., "The role of peptide growth factors in epithelial ovarian cancer," Obstet Gynecol, 75: 255-62 (1990). |
Brenner, R.M. et al., "Cyclic changes in the primate oviduct and endometrium. In: Knobil E, Neill JD, eds. The Physiology of reproduction," New York: Raven Press, pp. 541-569 (1994). |
Bu, SZ et al., "Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines," Cancer, 79: 1944-5.0 (1997). |
Bundesverband der Pharmazeutishen Industrie, "Rote liste 1995," Ecv. Editio Cantor, Aulendorf(DE), pp. 75023-75024 (1995). |
Chan, LN et al., "N-(4-hydroxyphenyl) retinamide prevents development of Tlymphomas in AKR/J mice," Anticancer Research, 17:499-503 (1997). |
Cohen, J.J., "Apoptosis," Immun Today 14:126-130 (1993). |
Delia, D. et al., "N-(4-hydroxyphenyl) retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid," Cancer Res., 53(24):603641 (1993). |
Eguchi, Y. et al., "Isolation and characterization of the chicken bcl-2 gene: expression in a variety of tissues including lymphoid and neuronal organs in adult and embryo," Nucleic Acids Research, 20(16) :4187-41922 (1992). |
el-Bayoumy, K. et al., "Chemo prevention of cancer by organoselenium compounds," J Cell Biochem, Suppl., 22: 92-100 (1995). |
Ellis, R. et al., "Mechanisms of cell death," Ann Rev Cell Bio, 17: 663-698 (1991). |
Evans, D.L. et al., "Molecular evolution and secondary structural conservation in the B-cell lymphoma leukemia 2 (bcl-2) family of proto-oncogene products," J Mol Evol., 41(6):775-83 (1995). |
Fredrickson, T.N. et al., "Ovarian tumors of the hen," Environ Health Perspect, 73:35-51(1987). |
Gentry, L.E. et al., "Type I transforming growth factor-beta: Amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells," Mol Cell Biol, 7:3418-27 (1987). |
Grimes et al., "Primary Prevention of Gynecologic Cancers," Am J. Obstetrics and Gynecology, 172(1):227-235 (1995). |
Havrilesky, L.J. et al., "Regulation of Apoptosis in Normal and Malignant Ovarian Epithelial Cells by Transforming Growth Factor .beta.," Cancer Research, 55:944-948 (Feb. 15, 1995). |
Hickey, M.J. et al., " Metabolic and Endocrinologic Effects of Steroidal Contraception Obstetrics," Ch 24, J. Sciarra, Editor, 1996 revised edition, Lippincott, Philadelphia, pp. 1-14 (1996). |
Hotchkiss, J. et al., "The menstrual cycle and its neuroendocrine control," In: Knobil E, Neill JD, eds. The Physiology of Reproduction. New York: Raven Press, pp. 711-736 (1994). |
Hurteau, J.A. et al., "Transforming growth factor-.beta. inhibits proliferation of human ovarian cancer cells obtained from ascites," Cancer, 74: 93-99 (1994). |
Johnson, A.J. et al., "Expression of bcl-2 and nr-13 in hen ovarian Follicles during development," Biol Repro, 57: 1097-1103 (1997). |
Kaiserman-Abramof, I. et al., "UItrastructural epithelial conation of the primate endometrium. (rhesus monkey)," Am J Anat, pp. 13-30 (1989). |
Lingeman, C.H., "Etiology of cancer of the human ovary," A review, J Natl Cancer Inst, 53:1603-1618 (1974). |
Lotan, R., "Retinoids in cancer chemo prevention," [Review] FASEB J., 10(9):1031-9, (1996). |
Lumbiganon, P., "Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary," Contraception, 49:203-209 (Mar., 1994). |
Mulheron, G.W. et al., "Rat thecal/interstitial cells express transforming growth factor-beta type 1 and 2 is regulated by gonadotropin in vitro," Endocrin, 129:368-3 73 (1991). |
Mulheron, G.W. et al., "Rat granulosa cells express transforming growth factor-beta type 2 messenger ribonucleic acid which is regulatable by fillide stimulating hormone in vitro," Endocrin, 126: 1771-1779 (1990). |
Mutch, D.G. et al., " Biology of epithelial ovarian cancer," Clin Obstet Gynecol, 37: 406-422 (1994). |
O'Brien, V. et al., "Expression of the integrin alpha 5 subunit in HT29 colon carcinoma cells suppresses apoptosis triggered by serum deprivation," Ex.Cell Res, 244(1):208-213 (1996). |
Oberhammer, F.A. et al., "Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-.beta.1," Proc Natl. Acad Sci USA, 89:5408-5412 (1992). |
Oridate, N. et al., "Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implications for chemo prevention," J Cell Biochem, Suppl, 23:80-6 (1995). |
Pascale, R.M. et al., "Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promosted by orotic acid," Carcinogenesis 16(2):427-30 (1995). |
Pfleiderer, "die Problematik einer prophylaktischen Chemotherapie, einer der Remission bei der Therapie des Ovarialkarzinoms," Geburstsh. u. Frauenheilk, 36(2):132-139 (1976). |
Physician's Desk Reference 1996, Product Information, pp. 1871-1876 2136-2138 2601-2604 2759-2762 and 2813-2818 (1996). |
Ponzoni, M. et al., "Differential effects of N-(4-hydroxyphenyl) retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation," Can Res., 55(4):853-61 (1995). |
Qin, S. et al., "Cooperation of tyrosine kinases p72syk and p53/56lyn regulates calcium mobilization in chicken B cell oxidant stress signaling," Eur J Biochem, 236(2):443-9 (1996). |
Rampalli, A.M. et al., "Insulin regulates expression of c-fos and c-jun and suppresses apoptosis of lens epithelial cells," Cell Growth Differ, 6(8):945-53 (1995). |
Reddy, B.S. et al., "Chemo prevention of colon carcinogenesis by dietary perillyl alcohol," Cancer Res., 57(3):420-5 (1997). |
Roberts, A.B. et al., "Mechanistic interrelationships between two superfamilies: The steroid/retinoid receptors and transforming growth factor-.beta.," In: Cancer Surveys, vol. 14: Growth Regulation hy Nuclear Hormone Receptors, Imperial Cancer Research Fund, pp. 205-217 (1992). |
Rodriguez, G.C. et al., "Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer.II. Relationship between receptor expression and response to epidermal growth factor," Am J Obstet Gynecol, 164: 745-750 (1991). |
Rotello, R.J. et al., "Coordinated regulation of apoptosis and cell proliferation by transforming growth factor-.beta.1 in cultured uterine epithelial cells," Proc Natl Acad Sci USA, 88: 3412-3415 (1991). |
Rudel, H. W., "Pharmacology of Contraceptive Steroids," Chapter 19, In: Gynecology -and Obstetrics J. Sciarra, Editor, 1996 revised edition, Lippincott, Philadelphia, pp. 1-6 (1996). |
Sankaranarayanan, R. et al., "Retinoids as cancer-preventive agents," [Review] IARC Sci Publ, (139):47-59 (1996). |
Schildkraut, J.M. et al., "Relationship Between Lifetime Ovulatory Cycles and Overexpression of Mutant p53 in Epithelial Ovarian Cancer," J. National Cancer Institute, 89(13):932-938 (Jul. 2, 1997). |
Scott, J.S., "How to induce ovarian cancer: and how not to," British Medical J., 289:781-784 (Sep. 29, 1984). |
Seewaldt, V.L. et al., "All-trans-retinoic acid mediates GI arrest but not apoptosis of normal human mammary epithelial cells," Cell Growth Differ., 6(7): 863-9 (1995). |
Syvala, H. et al., "Expression of the chicken progesterone receptor forms A and B is differentially regulated by estrogen in vivo," Biochemical and Biophysical Research Communications, 231: 573-576 (1997). |
Taetle, R. et al., "Effects of transforming growth factor-.beta.1 on growth and apoptosis of human acute myelogenous leukemia cells," Cancer Research, 53: 3386-3393 (1993). |
Takayama, S. et al., "Evolutionary conservation of function among mammalian, avian, and viral homologs of the bcl-2 oncoprotein," DNA Cell Biol, 13(7):679-92 (1994). |
Thompson, H.J. et al., "Sulfone metabolite of sulindac; inhibits mammary carcinogenesis," Cancer Res., 57(2):267-71 (1997). |
Thompson, H.J. et al., "Ip C. Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line,"Carcinogenesis 15(2):183-6 (1994). |
Toma, S. et al., "Effects of al-trans-retinoic acid and 13-cis-retinoic acid on breast-cancer cell lines : growth inhibition and apoptosis induction," Int J Cancer, 70(5):619-27 (1997). |
Vilgrasa, X. et al., "Differential expression of bcl-2 and bcl-x during chicken spermatogenesis," Mol Reprod Dev, 47(1):26-9 (1997). |
Wakefield, L. et al., "Regulation of transforming growth factor-.beta. subtypes by members of the steroid hormone superfamily," J Cell Sci Suppl, 13: 139-148 (1990). |
Wijsman, J.H. et al., "A new method to detect apoptosis in paraffin sections: In situ end- labeling of fragmented DNA," J Histochem Cytochem, 41:7-12 (1993). |
Woolveridge, I. et al., "The inhibition of androstenedione production in mature thecal cells from the ovary of the domestic hen (Gallus domesticus): evidence for the involvement of progestins," Steroids, 62: 214-220 (1997). |
Yanagihara, K. et al., "Transforming growth factor-.beta.1 induces apoptotic cell death in cultured human gastric carcinoma cells," Cancer Res, 52: 4042-4045 (1992). |
PCT International Search Report; PCT/US97/16601, (1997). |
Dolivet et al. [Current knowledge on the action of retinoids in carcinoma of the head and neck]. [Review], Rev. Laryngol. Otol. Rhinol. (Bord) 117(1):19-26, 1996 (English abstract). |
Etches et al., "Reptilian and avian follicular hierarchies: Models for the study of ovarian development," J. Exp. Zoo., Suppl 4:112-122, 1990. |
Fukuda et al., "Induction of apoptosis by transforming growth factor-1 in the rat hepatoma cell fine McA-RH7777: A possible associate with tissue transglutaminase expression," Hepatology, 18:945-953, 1993. |
Gould, "Cancer chemoprevention and therapy by monoterpenes," Environ. Health Perspect., 105 (Suppl 4):977-9, 1997. |
Kuo, "Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells," Cancer Lett., 110(1-2):41-8, 1996. |
Mayr et al., "Sequence of an exon of tumour suppressor p53 gene--a comparative study in domestic animals: mutation in a feline comparative study in domestic animals; mutation in a feline solid mammary carcinoma," Br. Vet. J., 151(3):325-9, 1995. |
Wilson "Adeno-carcinomata in hens kept in a constant environment," Poult. Sci., 37:1253 (1958). |
Miligan and Schwartz, Programmed Cell Death During Development of Animals, Cellular Aging and Cell Death: 181-208, 1996 (Wiley-Liss Inc., Eds.: Holbrook, Martin, and Lockshin). |
Canman et al., DNA Damage Responses: P-53 Induction, Cell Cycle Pertubations, and Apoptosis, Cold Spring Harbor Symp. Quant. Biol., 59: 277-286 (1994). |
Baker et al., Etiology, Biology, and Epidemiology of Ovarian Cancer, Seminars in Surgical Oncology 10: 242-248 (1994). |
Amos et al., Genetic Epidemiology of Epithelial Ovarian Cancer, Cancer 71: 566-72 (1993). |
Wittemore, Characteristics Relating To Ovarian Cancer Risk: Implications for Preventing and Detection, Gynecologic Oncology 55: S15-S19, 1994. |
Greene et al., The Epidemiology of Ovarian Cancer, Seminars in Oncology, 11: 209-225 (1984). |
Wittemore et al., Characteristics Relating To Ovarian Cancer Risk: Collaborative Analysis of 12 US Case-Control Studies, Am. J. Epidem. 136: 1212-20 (1992). |
Wu et al., Personal and Environmental Characteristics Related To Epithelial Ovarian Cancer, Am. J. Epidem., 108(6) : 1216-1227 (1988). |
Rossing et al., Ovarian Tumors in a Cohort Of Infertile Women, New Engl. J. Med., 331: 771-6 (1994). |
Casagrande et al., "Incessant Ovulation" and Ovarian Cancer, Lancet at 170-72 (Jul. 28, 1979). |
Rosenberg et al., A Case Control Study Of Oral Contraceptive Use and Invasive Epithelial Ovarian Cancer, Am. J. Epidem., 139: 654-61 (1994). |
Stanford et al., Epithelial Ovarian Cancer and Combined Oral Contraceptives, Int'l J. Epidem., 18: 538-45 (1989). |
Lee et al., The Reduction in Risk of Ovarian Cancer Associated with Oral Contraceptive Use, New Engl. J. Med., 316: 650-55 (1987). |
Gross and Schlesselman, The Estimated Effect of Oral Contraceptive Use on the Cumulative Risk of Epithelial Ovarian Cancer, Obstetrics Gynecology, 83: 419-24 (1994). |
Franseschi et al., Pooled Analysis of 3 European Case-Control Studies of Epithelial Ovarian Cancer: III. Oral Contraceptive Use, Int'l J. Cancer, 49: 61-65 (1991). |
Rosenblatt et al., High-Dose and Low-Dose Combined Oral Contraceptives: Protection Against Epithelial Ovarian Cancer and The Length of the Protective Effect, Eur. J. Cancer, 28A: 1872-76, 1992. |
Sanford and Thomas, Depot-Medroxyprogesterone Acetate (DMPA) and Risk of Epithelial Ovarian Cancer, Int'l J. Cancer, 49: 191-195 (1991). |
Liang et al., Risk of Breast, Uterine Corpus, and Ovarian Cancer in Women Receiving Medroxyprogesterone Injections, JAMA, 249: 2909-2912 (1983). |
Lowe and Ruley, P53-Dependent Apoptosis in Tumor Progression and in Cancer Therapy, Cellular Aging and Cell Death: 209-234, 1996 (Wiley-Liss Inc., Eds.: Holbrook, Martin, and Lockshin). |
Lockshin and Zakeri, The Biology of Cell Death and Its Relationship to Aging, Cellular Aging and Cell Death: 167-180, 1996 (Wiley-Liss Inc., Eds.: Holbrook, Martin, and Lockshin). |
Ovarian Cancer, Harrison's Principles of Internal Medicine, 13th ed., Ch. 321: 1853-1858, Ch. 340: 2017-2036 (Isselbacher et al., eds., McGraw-Hill, N.Y., 1994. |
Rodriguez et al., Estrogen Replacement Therapy and Fatal Ovarian Cancer, Am. J. Epidem., 141: 828-835 1995. |